Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cells
Objective(s): Checkpoint blocking is considered a revolutionary method in cancer treatment. This method eliminates cancer cells by maintaining the sensitivity of immune cells. Today, cell therapy through checkpoint blocking is known as the most efficient method of cancer treatment. The programmed ce...
Main Authors: | Seyed Ali Alambeladi, Seyed Ebrahim Hosseini, Mojtaba Jafarinia, Mehdi Dianatpour |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2021-01-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://ijbms.mums.ac.ir/article_16961_ce5c071b0fa128c6821ae69f5210dfe9.pdf |
Similar Items
-
Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
by: Tsutomu Nakazawa, et al.
Published: (2020-04-01) -
Multipl miyelom’da CD4+ regülatör T hücrelerin rolü
by: Deniz EKİNCİ, et al.
Published: (2017-09-01) -
Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
by: Soraya Ahmadi-Balootaki, et al.
Published: (2022-09-01) -
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
by: Alfredo Addeo, et al.
Published: (2019-04-01) -
Association between <i>AHR</i> Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells
by: Arenida Bartkeviciene, et al.
Published: (2023-09-01)